• FAM83A, CK1, and Mitochondrial Adipogenesis

  2026-08-25

  The reference study identifies FAM83A as a regulator of white adipocyte differentiation that links casein kinase 1 activity to mitochondrial outer-membrane maintenance. By using FITC-ATS-9R to deliver a FAM83A-sgRNA/Cas9 construct in mice, the authors connect adipose-tissue gene perturbation with reduced fat deposition, impaired lipid formation, mitochondrial dysfunction, and apoptosis.

• Treponema pallidum and Mitochondrial Apoptosis

  2026-08-24

  The reference study links Treponema pallidum exposure to intrinsic apoptosis in THLE-2 hepatocytes through mitochondrial ROS accumulation, cardiolipin peroxidation, and loss of mitochondrial function. Its strongest contribution is the integration of mitochondrial permeability, redox, membrane-potential, ATP, and apoptotic readouts, while ROS-inhibition experiments provide evidence for an upstream role of oxidative stress.

• CHIR 99021 Trihydrochloride for Organoids

  2026-08-24

  Learn how to use CHIR 99021 trihydrochloride as a controlled GSK-3 inhibitor in intestinal organoid, stem-cell, and metabolic research. This practical guide combines reference-backed principles with dose planning, assay design, and troubleshooting for balancing proliferation with cellular diversity.

• MFGE8–ANXA1/SMAD2/3 Targeting in Pancreatic Fibrosis

  2026-08-23

  This study identifies an MFGE8-dependent ANXA1–SMAD2/3 signaling axis through which umbilical cord-derived mesenchymal stem cell extracellular vesicles suppress pancreatic stellate cell activation and fibrosis. It also develops rhMFGE8 nanoparticles as a cell-free antifibrotic platform, connecting regenerative biology with targeted nanomedicine for chronic pancreatitis.

• MG-132 for Reliable Cell Assays

  2026-08-22

  Learn how MG-132 (SKU A2585) can help researchers troubleshoot variable viability, apoptosis, cell-cycle, and oxidative-stress experiments. This scenario-driven guide connects product specifications with practical decisions about dosing, controls, storage, interpretation, and vendor reliability.

• BMS-345541: Mapping NF-κB in Vascular Inflammation

  2026-08-21

  BMS-345541 is an IKK-1/IKK-2 inhibitor for testing how NF-κB controls cytokines, endothelial behavior, and tumor-cell survival. This article interprets vascular pathway-inhibition data as a causal assay framework rather than a routine product overview.

• GPX4 and GSH Drive Platinum Resistance in Brain Metastasis

  2026-08-20

  The reference study identifies a glutathione high-consumption state as a metabolic feature of lung cancer-derived brain metastasis and connects it to GPX4/GSTM1-mediated suppression of ferroptosis. Its integrated model-based, multi-omic, biochemical, and transcriptional experiments suggest that disrupting GPX4 can restore platinum sensitivity, although validation across patient-derived systems remains necessary.

• PGE2 in Pancreatic Ductal Organoids

  2026-08-20

  Discover how Prostaglandin E2 can function as a controlled signaling perturbation in pancreatic ductal organoids. This guide connects EP-receptor pharmacology with organoid assay design, emphasizing reproducibility, receptor attribution, and practical reagent handling.

• EMSC Transplantation Modulates Microglia After ICH

  2026-08-19

  This 2026 study shows that nasal ectomesenchymal stem cell transplantation can reduce post-hemorrhagic brain injury while shifting microglia toward an anti-inflammatory state and increasing IL-10. Its combined mouse, co-culture, transcriptomic, and pathway-validation design links the cellular response to suppression of NF-κB and MAPK signaling, although further causal and translational studies are needed.

• TBXA2R–ERM Signaling in TNBC Metastasis

  2026-08-19

  Leguay and colleagues identify TBXA2R as a GPCR that activates ezrin, radixin, and moesin through Gαq/11, Gα12/13, Rho GTPases, and the kinases SLK and LOK. The resulting TBXA2R–ERM axis promotes triple-negative breast cancer motility, invasion, and metastatic colonization, providing a mechanistic link between GPCR signaling and cancer-cell cytoskeletal remodeling.

• How Fasting Rewires Translation and Tumor Metabolism

  2026-08-18

  Yang and colleagues show that fasting suppresses global hepatic translation while selectively activating translation of ketogenesis-related mRNAs through the AMPK–MNK–eIF4E pathway. The study also links this fatty-acid-responsive translational circuit to pancreatic tumor growth, providing a mechanistic basis for combining dietary intervention with P-eIF4E inhibition.

• Platycodin D Targets RFC4 in NSCLC

  2026-08-18

  This 2026 Molecular & Cellular Proteomics study combines thermal proteome profiling, cellular validation, peptide-level stability analysis, and proteomics to identify RFC4 as a functional target of Platycodin D in non-small cell lung cancer. The findings connect RFC4 engagement with altered Notch1/Notch3 signaling, ubiquitination changes, and cancer-cell apoptosis, while also defining important limits for model and mechanism transferability.

• Linoleic Acid Workflows for Oxidative Stress

  2026-08-17

  Build reproducible Linoleic Acid workflows for oxidative stress, membrane, erythrocyte, migration, and deficiency studies. The guide separates practical starting conditions from findings in fasting-related translational research, helping researchers choose informative controls and avoid common lipid-handling artifacts.

• HOXC8, Caspase-1, and Pyroptosis in Lung Cancer

  2026-08-17

  The reference study identifies HOXC8 as a transcriptional suppressor of caspase-1 expression in non-small cell lung carcinoma, revealing a mechanism by which tumor cells avoid pyroptotic death. Its combination of genetic, pharmacological, transcriptional, and in vivo evidence links HOXC8–HDAC1/2 regulation to lung tumorigenesis and provides a framework for separating pyroptosis from apoptosis in cancer research.

• Pioglitazone: PPARγ Agonist Workflow Guide

  2026-08-16

  Pioglitazone provides a practical way to connect PPARγ activation with metabolic regulation, macrophage polarization, and tissue-protective phenotypes. This guide translates recent DSS colitis findings into reproducible cell and animal workflows, with formulation, controls, and troubleshooting guidance.

555 records 7/37 page Previous Next First page 上5页 678910 下5页 Last page